The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg74

被引:203
作者
Cain, SA [1 ]
Monk, PN [1 ]
机构
[1] Univ Sheffield, Sch Med, Dept Neurol, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
10.1074/jbc.C100714200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The substantial variations in the responses of cells to the anaphylatoxin C5a and its desarginated form, C5adR(74), suggest that more than one type of cell surface receptor for these ligands might exist. However, only a single receptor for C5a and C5adR(74), CD88, has been characterized to date. Here we report that the orphan receptor C5L2/gpr77, which shares 35% amino acid identity with CD88, binds C5a with high affinity but has a 10-fold higher affinity for C5adR(74) than CD88. C5L2 also has a moderate affinity for anaphylatoxin C3a, but cross-competition studies suggest that C3a binds to a distinct site from C5a. C4a was able to displace C3a, suggesting that C5L2, like the C3a receptor, may have a low binding affinity for this anaphylatoxin. Unlike CD88 and C3a receptor, C5L2 transfected into RBL-2H3 cells does not support degranulation or increases in intracellular [Ca2+] and is not rapidly internalized in response to ligand binding. However, ligation of C5L2 by anaphylatoxin did potentiate the degranulation response to cross-linkage of the high affinity IgE receptor by a pertussis toxin-sensitive mechanism. These results suggest that C5L2 is an anaphylatoxin-binding protein with unique ligand binding and signaling properties.
引用
收藏
页码:7165 / 7169
页数:5
相关论文
共 31 条
  • [1] Cutting edge: Differential regulation of chemoattractant receptor-induced degranulation and chemokine production by receptor phosphorylation
    Ahamed, J
    Haribabu, B
    Ali, H
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (07) : 3559 - 3563
  • [2] ALI H, 1994, J BIOL CHEM, V269, P24557
  • [3] ALI H, 1993, J BIOL CHEM, V268, P24247
  • [4] Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury
    Bhatia, M
    Saluja, AK
    Singh, VP
    Frossard, JL
    Lee, HS
    Bhagat, L
    Gerard, C
    Steer, ML
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2001, 280 (05): : G974 - G978
  • [5] The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization
    Bock, D
    Martin, U
    Gartner, S
    Rheinheimer, C
    Raffetseder, U
    Arseniev, L
    Barker, MD
    Monk, PN
    Bautsch, W
    Kohl, J
    Klos, A
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (06) : 1522 - 1529
  • [6] ANAPHYLATOXIN INACTIVATOR OF HUMAN PLASMA - ITS ISOLATION AND CHARACTERIZATION AS A CARBOXYPEPTIDASE
    BOKISCH, VA
    MULLEREB.HJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1970, 49 (12) : 2427 - &
  • [7] EXPRESSION CLONING OF A RECEPTOR FOR C5A ANAPHYLATOXIN ON DIFFERENTIATED HL-60 CELLS
    BOULAY, F
    MERY, L
    TARDIF, M
    BROUCHON, L
    VIGNAIS, P
    [J]. BIOCHEMISTRY, 1991, 30 (12) : 2993 - 2999
  • [8] Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries
    Cain, SA
    Ratcliffe, CF
    Williams, DM
    Harris, V
    Monk, PN
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 245 (1-2) : 139 - 145
  • [9] Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor
    Cain, SA
    Woodruff, TM
    Taylor, SM
    Fairlie, DP
    Sanderson, SD
    Monk, PN
    [J]. BIOCHEMICAL PHARMACOLOGY, 2001, 61 (12) : 1571 - 1579
  • [10] Mapping the ligand-binding site on the C5a receptor:: Arginine74 of C5a contacts aspartate282 of the C5a receptor
    Cain, SA
    Coughlan, T
    Monk, PN
    [J]. BIOCHEMISTRY, 2001, 40 (46) : 14047 - 14052